| Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators. | |
| | |
MedLine Citation:
|
PMID: 21712098 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Control of the inflammatory response is of wide interest given its important role in many diseases. In recent years we identified novel mechanisms and lipid mediators that play an active role in stimulating the resolution of self-limited acute inflammation. These novel pro-resolving mediators include the essential fatty acid-derived lipoxins, resolvins, protectins and maresins. Members of each possess a unique pro-resolving mechanism of action; each limits neutrophilic infiltration, regulates local mediators (chemokines, cytokines) as well as stimulates macrophage-enhanced clearance of apoptotic PMN, cellular debris and microbes. Given this unique mechanism of action, resolvins have already been shown to play pivotal roles in regulating key events in a wide range of experimental inflammatory diseases. These pro-resolving mediators also provide a molecular link between omega-3 essential fatty acids (e.g. EPA, DHA) and the resolution process of inflammation and tissue homeostasis. Here, we review recent evidence obtained using chiral LC-MS-MS-based lipidomics to identify a novel 18S-series of resolvins derived from EPA. Resolvin E1 possesses potent actions in vivo and in vitro demonstrated now in many laboratories, and herein we review comparisons in E-series resolvin biosynthesis and action of 18S-resolvin E1 and 18S-resolvin E2. The biosynthesis and formation of both 18S and 18R-series are enhanced with aspirin treatment and involve the utilization of dietary EPA as well as recombinant human 5-lipoxygenase and LTA(4) hydrolase in their stereospecific biosynthesis. Herein we also demonstrate the utility of LC-MS-MS-based lipidomics in identifying resolvins, protectins and related products in marine organisms such as Engraulis (Peruvian anchovy). These new findings emphasize the utility of chiral LC-MS-MS lipidomics and the potential for identifying new resolution circuits with chiral LC-MS-MS-based lipidomics and metabolomics. |
| | |
Authors:
|
Sungwhan F Oh; Thad W Vickery; Charles N Serhan |
Related Documents
:
|
15618008 - Ticam-1 and ticam-2: toll-like receptor adapters that participate in induction of type ... 16394008 - Abrupt expression of tlr4 in tlr4-deficient macrophages imposes a selective disadvantag... 16738018 - Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. 21080068 - Cellular stress responses, mitostress and carnitine insufficiencies as critical determi... 21283568 - Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and... 17049678 - Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune ... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review Date: 2011-06-16 |
Journal Detail:
|
Title: Biochimica et biophysica acta Volume: 1811 ISSN: 0006-3002 ISO Abbreviation: Biochim. Biophys. Acta Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-10-31 Completed Date: 2012-01-19 Revised Date: 2012-04-25 |
Medline Journal Info:
|
Nlm Unique ID: 0217513 Medline TA: Biochim Biophys Acta Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 737-47 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier B.V. All rights reserved. |
Affiliation:
|
Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. soh@zeus.bwh.harvard.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Arachidonate 5-Lipoxygenase / metabolism Aspirin / pharmacology* Docosahexaenoic Acids / analysis*, biosynthesis, chemistry* Epoxide Hydrolases / metabolism Humans Inflammation Mediators / metabolism* Lipid Metabolism / drug effects* |
| Grant Support | |
ID/Acronym/Agency:
|
DE019938/DE/NIDCR NIH HHS; GM38765/GM/NIGMS NIH HHS; R01 DE019938-01/DE/NIDCR NIH HHS; R01 DE019938-02/DE/NIDCR NIH HHS; R01 DE019938-03/DE/NIDCR NIH HHS; R01 DE019938-04/DE/NIDCR NIH HHS; R01 GM038765/GM/NIGMS NIH HHS; R37 GM038765-21/GM/NIGMS NIH HHS; R37 GM038765-22/GM/NIGMS NIH HHS; R37 GM038765-23/GM/NIGMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Inflammation Mediators; 25167-62-8/Docosahexaenoic Acids; 50-78-2/Aspirin; EC 1.13.11.34/Arachidonate 5-Lipoxygenase; EC 3.3.2.-/Epoxide Hydrolases; EC 3.3.2.-/leukotriene A4 hydrolase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Raw attitudes, wetland cultures, life-cycles: Socio-cultural dynamics relating to Opisthorchis viver...
Next Document: A clonal strain of Trichomonas gallinae is the aetiologic agent of an emerging avian epidemic diseas...